Form SC 13D/A - General Statement of Acquisition of Beneficial Ownership: [Amend]
SEC Accession No. 0001104659-24-097369
Filing Date
2024-09-05
Accepted
2024-09-05 16:07:46
Documents
1
Group Members
ADIUMENTUM CAPITAL FUND I GP LLCGREGORY A. CIONGOLI

Document Format Files

Seq Description Document Type Size
1 SC 13D/A tm2423241d1_sc13da.htm SC 13D/A 68833
  Complete submission text file 0001104659-24-097369.txt   70618
Mailing Address 2380 CONEJO SPECTRUM ST SUITE 200 THOUSAND OAKS CA 91320
Business Address 2380 CONEJO SPECTRUM ST SUITE 200 THOUSAND OAKS CA 91320 805-623-4244
Atara Biotherapeutics, Inc. (Subject) CIK: 0001604464 (see all company filings)

EIN.: 460920988 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A | Act: 34 | File No.: 005-88393 | Film No.: 241281462
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)

Mailing Address 30 GREYLOCK ROAD WELLESLEY MA 02481
Business Address 30 GREYLOCK ROAD WELLESLEY MA 02481 781-235-7974
Adiumentum Capital Fund I LP (Filed by) CIK: 0002023734 (see all company filings)

EIN.: 992041819 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13D/A